Barclays analyst Balaji Prasad downgraded Viatris to Equal Weight from Overweight with an $11 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VTRS:
- Viatris says wins summary judgment in New York securities class action
- Viatris seeks new OTC unit bids after initial offers disappoint, Bloomberg says
- Regeneron price target raised to $940 from $925 at Jefferies
- Viatris call volume above normal and directionally bullish
- Viatris price target raised to $16 from $15 at Barclays